Antibody discovery: Phage display

Current Opinion in Biotechnology

Volumn 13, Issue 6, 2002, Pages 598-602

  Kretzschmar, Titus ^a   Von Rüden, Thomas ^a  

^a MORPHOSYS AG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; DNA ANTIBODY; EPIDERMAL GROWTH FACTOR RECEPTOR; EPITOPE; IMMUNOGLOBULIN F(AB) FRAGMENT; OKT 3; PROTEOME; PEPTIDE LIBRARY;

ANTIBODY AFFINITY; ANTIBODY ENGINEERING; ANTIBODY ISOLATION; ANTIBODY LIBRARY; ANTIGEN SPECIFICITY; B LYMPHOCYTE; BACTERIOPHAGE; ELECTROPHORESIS; ESCHERICHIA COLI; FOOD AND DRUG ADMINISTRATION; HUMAN; HYBRIDOMA; IN VITRO STUDY; IN VIVO STUDY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEOMICS; REVIEW; TECHNOLOGY; ANTIBODY SPECIFICITY; GENETICS; IMMUNOGLOBULIN GENE; IMMUNOLOGY; ISOLATION AND PURIFICATION;

ESCHERICHIA COLI;

ANTIBODIES; ANTIBODY SPECIFICITY; BACTERIOPHAGES; GENES, IMMUNOGLOBULIN; PEPTIDE LIBRARY;

EID: 0036899599     PISSN: 09581669     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0958-1669(02)00380-4     Document Type: Review

References (48)

1. Köhler G., Milstein C. Continuous cultures of fused cells secreting antibody of predefined specificity. Nature. 256:1975;495-497.
2. Reichert J.M. Therapeutic monoclonal antibodies: trends in development and approval in the US. Curr Opin Mol Ther. 4:2002;110-118.
3. Better M., Chang C.P., Robinson R.R., Horwitz A.H. Escherichia coli secretion of an active chimeric antibody fragment. Science. 240:1988;1041-1043.
4. Skerra A., Plückthun A. Assembly of a functional immunoglobulin Fv fragment in Escherichia coli. Science. 240:1988;1038-1041.
5. Smith G.P. Filamentous fusion phage: novel expression vectors that display cloned antigens on the virion surface. Science. 228:1985;1315-1317.
6. McCafferty J., Griffiths A.D., Winter G., Chiswell D.J. Phage antibodies: filamentous phage displaying antibody variable domains. Nature. 348:1990;552-554.
7. Rosenberg A., Griffin K., Studier F.W., McCormick M., Berg J., Novy R., Mierendorf R. T7Select® phage display system: a powerful new protein display system based on bacteriophage T7. Innovations (Newsletter of Novagen Inc.). 6:1996;1-6.
8. Holt L.J., Enever C., de Wildt R.M.T., Tomlinson I.M. The use of recombinant antibodies in proteomics. Curr Opin Biotechnol. 11:2000;445-449.
9. Hoogenboom H.R. Designing and optimizing library selection strategies for generating high-affinity antibodies. Trends Biotechnol. 15:1997;62-70.
10. Roovers R.C., van der Linden E., Zijlema H., de Bruïne A., Arends J.-W., Hoogenboom H.R. Evidence for a bias toward intracellular antigens in the local humoral anti-tumor immune response of a colorectal cancer patient revealed by phage display. Int J Cancer. 93:2001;832-840. An analysis of antibody specificities obtained by selecting either immune or non-immune phage libraries indicates that in vivo tolerance mechanisms had biased the specificities in the immune library towards intracellular targets. No cell surface reactive antibodies could be isolated, in contrast to the non-immune library.
11. Knappik A., Ge L., Honegger A., Pack P., Fischer M., Wellnhofer G., Hoess A., Wölle J., Plückthun A., Virnekäs B. Fully synthetic human combinatorial antibody libraries (HuCAL) based on modular consensus frameworks and CDRs randomized with trinucleotides. J Mol Biol. 296:2000;57-86. The authors describe in great detail the design of a synthetic, human scFv phage display library useful for the generation of high quality antibodies. Key library features include modular gene design, antibody sequences being close to the germline configuration as well as efficient antibody expression.
12. Hoogenboom H.R., Winter G. By-passing immunisation. Human antibodies from synthetic repertoires of germline VH gene segments rearranged in vitro. J Mol Biol. 227:1992;381-388.
13. Vaughan T.J., Williams A.J., Pritchard K., Osbourn J.K., Pope A.R., Earnshaw J.C., McCafferty J., Hodits R.A., Wilton J., Johnson K.S. Human antibodies with sub-nanomolar affinities isolated from a large non-immunized phage display library. Nat Biotechnol. 14:1996;309-314.
14. Sheets M.D., Amersdorfer P., Finnern R., Sargent P., Lindquist E., Schier R., Hemingsen G., Wong C., Gerhart J.C., Marks J.D. Efficient construction of a large nonimmune phage antibody library: The production of high-affinity human single-chain antibodies to protein antigens. Proc Natl Acad Sci USA. 95:1998;6157-6162.
15. De Haard H.J., van Neer N., Reurs A., Hufton S.E., Roovers R.C., Henderikx P., de Bruïne A.P., Arends J.W., Hoogenboom H.R.A. A large non-immunized human Fab fragment phage library that permits rapid isolation and kinetic analysis of high affinity antibodies. J Biol Chem. 274:1999;18218-18230.
16. Krebs B., Rauchenberger R., Reiffert S., Rothe C., Tesar M., Thomassen E., Cao M., Dreier T., Fischer D., Höss A., et al. High-throughput generation and engineering of recombinant human antibodies. J Immunol Methods. 254:2001;67-84. The selection of high affinity human antibodies from a large synthetic phage library is described. Details about the antigen quality requirements for the successful library panning are given.
17. Nagy Z.A., Hubner B., Löhning C., Rauchenberger R., Reiffert S., Thomassen-Wolf E., Zahn S., Leyer S., Schier E.M., Zahradnik A., et al. Fully human, HLA-DR-specific monoclonal antibodies efficiently induce programmed death of malignant lymphoid cells. Nat Med. 8:2002;801-807.
18. Rader C., Barbas C.F. Phage display of combinatorial antibody libraries. Curr Opin Biotechnol. 8:1997;503-508.
19. Carter P., Merchant A.M. Engineering antibodies for imaging and therapy. Curr Opin Biotechnol. 8:1997;449-454.
20. Griffiths A.D., Duncan A.R. Strategies for selection of antibodies by phage display. Curr Opin Biotechnol. 9:1998;102-108.
21. Hoogenboom H.R., Chames P. Natural and designer binding sites made by phage display technology. Immunol Today. 21:2000;371-378.
22. Siegel D.L. Recombinant monoclonal antibody technology. Transfus Clin Biol. 9:2002;15-22.
23. Aa A. Barbas C.F. III, Burton D.R., Scott J.K., Silverman G.J. Phage Display: A Laboratory Manual. 2001;Cold Spring Harbor Laboratory Press, Plainview, NY.
24. Antibody phage display: Methods and protocols. In: Methods in Molecular Biology, Vol 178. Edited by O'Brien P.M. Aitken R. Totowa, NJ: Humana Press; 2001.
25. Goletz S., Christensen P.A., Kristensen P., Blohm D., Tomlinson I., Winter G., Karsten U. Selection of large diversities of antiidiotypic antibody fragments by phage display. J Mol Biol. 315:2002;1087-1097.
26. Marget M., Sharma B.B., Tesar M., Kretzschmar T., Jenisch S., Westphal E., Davarnia P., Weiss E., Ulbrecht M., Kabelitz D., et al. Bypassing hybridoma technology: HLA-C reactive human single-chain antibody fragments (scFv) derived from a synthetic phage display library (HuCAL) and their potential to discriminate HLA class I specificities. Tissue Antigens. 56:2000;1-9.
27. Johns M., George A.J., Ritter M.A. In vivo selection of scFv from phage display libraries. J Immunol Methods. 239:2000;137-151. For the first time, the in vivo selection of an antibody phage library is described. scFv specifically recognizing targets on the endothelium could be identified. The isolation of antibodies to complex and/or unknown targets in their natural environment is thus rendered feasible.
28. Becerril B., Poul M.A., Marks J.D. Toward selection of internalizing antibodies from phage libraries. Biochem Biophys Res Commun. 255:1999;386-393.
29. Heitner T., Moor A., Garrison J.L., Marks C., Hasan T., Marks J.D. Selection of cell binding and internalizing epidermal growth factor receptor antibodies from a phage display library. J Immunol Methods. 248:2001;17-30.
30. Bruggeman Y.E., Boogert A., van Hoek A., Jones P.T., Winter G., Schots A., Hilhorst R. Phage antibodies against an unstable hapten: oxygen sensitive reduced flavin. FEBS Lett. 388:1996;242-244.
31. Lou J., Marzari R., Verzillo V., Ferrero F., Pak D., Sheng M., Yang C., Sblattero D., Bradbury A. Antibodies in haystacks: how selection strategy influences the outcome of selection from molecular diversity libraries. J Immunol Methods. 253:2001;233-242.
32. Lee L.S., Conover C., Shi C., Whitlow M., Filpula D. Prolonged circulating lives of single-chain Fv proteins conjugated with polyethylene glycol: a comparison of conjugation chemistries and compounds. Bioconjug Chem. 10:1999;973-981.
33. Leong S.R., DeForge L., Presta L., Gonzalez T., Fan A., Reichert M., Chuntharapai A., Kim K.J., Tumas D.B., Lee W.P., et al. Adapting pharmacokinetic properties of a humanized anti-interleukin-8 antibody for therapeutic applications using site-specific PEGylation. Cytokine. 16:2001;106-119. A humanized, affinity optimized Fab′ fragment was conjugated to polyethyleneglycol molecules of different molecular weights. The pharmocokinetic properties could be tailored to result in values nearly identical to those obtained with the IgG without loss of efficacy in vivo.
34. O'Donovan C., Apweiler R., Bairoch A. The human proteomics initiative (HPI). Trends Biotechnol. 19:2001;178-181.
35. Holt L.J., Bussow K., Walter G., Tomlinson I.M. By-passing selection: direct screening for antibody-antigen interactions using protein arrays. Nucleic Acids Res. 28:2000;E72.
36. de Wildt R.M., Mundy C.R., Gorick B.D., Tomlinson I.M. Antibody arrays for high-throughput screening of antibody-antigen interactions. Nat Biotechnol. 18:2000;989-994.
37. Cahill D.J. Protein and antibody arrays and their medical applications. J Immunol Methods. 250:2001;81-91.
38. Kodadek T. Protein microarrays: prospects and problems. Chem Biol. 8:2001;105-115.
39. Haab BB, Dunham MJ, Brown PO: Protein microarrays for highly parallel detection and quantitation of specific proteins and antibodies in complex solutions. Genome Biol 2001, 2:RESEARCH 0004.
40. Abbott A. Betting on tomorrow's chips. Nature. 415:2002;112-114.
41. Brody E.N., Gold L. Aptamers as therapeutic and diagnostic agents. J Biotechnol. 74:2000;5-13.
42. Skerra A. Engineered protein scaffolds for molecular recognition. J Mol Recognit. 13:2000;167-187.
43. Skerra A. 'Anticalins': a new class of engineered ligand-binding proteins with antibody-like properties. J Biotechnol. 74:2001;257-275.
44. Legendre D., Vucic B., Hougardy V., Girboux A.L., Henrioul C., Van Haute J., Soumillion P., Fastrez J. TEM-1 beta-lactamase as a scaffold for protein recognition and assay. Protein Sci. 11:2002;1506-1518.
45. Hayhurst A., Georgiou G. High-throughput antibody isolation. Curr Opin Chem Biol. 5:2001;683-689. In this review the in vitro combinatorial antibody (phage) library technology is considered the most promising approach for large-scale antibody generation. The authors, however, conclude that the 'true litmus test' for application in proteomics for any method will be the success rate obtained with 'difficult' targets.
46. Liu B., Huang L., Sihlbom C., Burlingame A., Marks J.D. Towards proteome-wide production of monoclonal antibody by phage display. J Mol Biol. 315:2002;1063-1073. A novel procedure is described to select antibodies from phage libraries to western-blotted cellular proteins that have been separated by two-dimensional gel electrophoresis. The automation of this process is anticipated to allow high-throughput generation of antibodies for target identification/validation purposes.
47. Söderlind E., Strandberg L., Jirholt P., Kobayashi N., Alexeiva V., Aberg A.-M., Nilsson A., Jansson B., Ohlin M., Wingren C., et al. Recombining germline-derived CDR sequences for creating diverse single-framework antibody libraries. Nat Biotechnol. 18:2000;852-856.
48. Carlsson R., Söderlind E. n-CoDeR concept: unique types of antibodies for diagnostic use and therapy. Expert Rev Mol Diagn. 1:2001;102-108.